SUMMARY Acrosoxacin was given as a single 300 mg oral dose to 105 patients with acute gonorrhoea. Of the 100 patients followed completely there was a 93% cure rate and 33% of men developed postgonococcal urethritis (PGU). This compared with a 97% cure and 30% PGU with 2 megaunits penicillin. The in vitro activity of acrosoxacin in Nottingham against strains of Neisseria gonorrhoeae showed that it was a highly active agent with 90070 of strains inhibited by a concentration of 0-03 mg/l.
Introduction
Patients and methods
Single dose oral treatment of acute gonorrhoea is established practice in many clinics and we have had experience with minocycline in Nottingham.' Intramuscular penicillin remains the treatment of choice in our clinic, but with an increasing prevalence of resistance to penicillin it is important that other agents should be investigated. Acrosoxacin (Eradacin) is a new pyridyl-quinoline antibacterial agent related to nalidixic acid. It is rapidly absorbed when taken orally on an empty stomach, a dose of 300 mg attaining a peak plasma concentration of 6 6 mg/l after two to six hours. The plasma half-life ranges from four to 11 hours and 70% of the drug is protein-bound. The drug is inactivated in the liver and its metabolites mostly excreted in the urine, alt-hough about 4% is excreted unchanged (Sterling Winthrop, unpublished data Treatment was given on the basis of positive microscopy and in all cases the diagnosis was later confirmed by culture and identification of N gonorrhoeae by standard methods. Patients who were known to default were excluded from the trial as were pregnant or lactating women and patients with renal or hepatic impairment.
Patients were warned of possible side effects of the drug (that is, dizziness, drowsiness, headache, and gastrointestinal upset). Avoidance of sexual activity was advised for at least two weeks in every case. The patients were asked to attend for follow up three, seven, and 14 days after treatment. On each occasion smears and cultures were repeated.
Men with symptoms or signs or both of a urethral discharge which on microscopy of a Gram smear showed >10 leucocytes per microscopic field (x 1000) but no Gram-negative intracellular diplococci (GNDC), and whose urethral culture was negative, were diagnosed seven or more days after treatment as having postgonococcal urethritis (PGU) 
Results
The total number of patients treated was 105 (81 men and 24 women). Five men defaulted, 69 were cured, and there were seven treatment failures (all male) and no reinfections. Two patients with penicillinase-producing (PPNG) strains were treated: one was cured and the other failed with acrosoxacin. The only patient with complications-epididymitis-responded well to the single ortl dose. PGU occurred at the end of the first week after treatment in 15 men, at the end of the second week in nine men, and at the end of the third week in one. All the 24 women treated with acrosoxacin were cured including 12 cases with rectal infection. Five patients reported transient dizziness and nausea.
In a comparative study of 300 patients with uncomplicated gonorrhoea who were treated with penicillin, 97% were cured and 30/o of the men developed PGU. 
